Sun.Jul 28, 2024

article thumbnail

Is Medical Device Sales Worth It?

David Bagga

Medical Device Sales Academy Is Medical Device Sales Worth It? Medical device sales have become one of the most popular and rewarding careers in 2024. However, is it worth your time and attention? Do you want to enter medical device sales and earn a better living? When considering anything new, it can be pretty regular […] The post Is Medical Device Sales Worth It?

Medical 130
article thumbnail

FDA Approval of Alopecia Drug Positions Sun Pharma to Compete With Eli Lilly, Pfizer

MedCity News

Leqselvi is now FDA approved for treating severe alopecia areata. Sun Pharma added the oral drug to its pipeline via the $576 million acquisition of Concert Pharmaceuticals last year. The post FDA Approval of Alopecia Drug Positions Sun Pharma to Compete With Eli Lilly, Pfizer appeared first on MedCity News.

Pharma 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

LEO closes on first approval for chronic hand eczema drug

pharmaphorum

The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects

article thumbnail

The Bereavement Care Crisis in Hospice Facilities

MedCity News

Instead of pushing harder on hospice providers to find more ways to deliver comprehensive bereavement care with less, it’s key to address the systemic forces hampering their ability to deliver quality care at the scale required and address these challenges. The post The Bereavement Care Crisis in Hospice Facilities appeared first on MedCity News.

Patients 100
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms

PharmaTech

As the number of highly potent oral solid dose (HPOSD) drugs in development and on the market increases, so are regulator’s expectations regarding their safe manufacture. In this white paper Pfizer CentreOne examines what developers and their manufacturing partners need to know about its unique regulatory challenges and how to navigate HPOSD’s complex manufacturing environment successfully.

article thumbnail

Preserving Profitability: Why Financial Redundancy Is Vital in Healthcare

MedCity News

While hospitals have contingency plans for events like power outages and extreme weather — backup generators, secondary chillers, and fiber for internet coverage — they can typically neglect vulnerabilities in the revenue cycle. Here are five proactive measures for hospitals and revenue cycle management/clearing house partners. The post Preserving Profitability: Why Financial Redundancy Is Vital in Healthcare appeared first on MedCity News.

More Trending

article thumbnail

Balancing Risk and Opportunity to Choose Winning Therapies

MedCity News

The ability to take a drug to market is an important milestone, but it is not the entire picture. To truly move the needle, both clinically and commercially, biopharma companies must fine-tune their teams, approaches and incentives to produce unique and innovative products. The post Balancing Risk and Opportunity to Choose Winning Therapies appeared first on MedCity News.

article thumbnail

Raiz: The End of the Road in Malaysia

Contrarian Sales Techniques

Remember that app that let you invest your spare change? You know, the one called Raiz ? Yeah, that one. Well, it's no longer around in Malaysia. After being here for about four years, Raiz has decided to pack its bags and leave. What was Raiz, anyway? Raiz was like a friendly robot that helped you invest your money. You could start with as little as RM5 and it would suggest investments based on how much risk you were comfortable with.

52
article thumbnail

Stuck in the Middle: Employers’ Challenges In Accessing Their Health Data

MedCity News

Employers are starting to face lawsuits from employees for not fulfilling their fiduciary duty. However, employers are also struggling to access their claims data from their third party administrators, which makes it difficult to uphold their fiduciary responsibility, experts say. The post Stuck in the Middle: Employers’ Challenges In Accessing Their Health Data appeared first on MedCity News.

article thumbnail

Pharmaceutical Technology Excellence Awards 2024: SecureCHEK AI

Pharmaceutical Technology

SecureCHEK AI is a Category Award Winner in four areas in the 2024 Pharmaceutical Technology Excellence Awards

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model